Showing results (1-10 of 2,085) with videos related to
Sort By:
Pageof 209
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightDeepak L Bhatt, Eric J TopolAmerican Heart Journal|August 17, 2004
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Eric J Topol, Nature Reviews. Drug Discovery|January 2, 2003
Scientific and therapeutic advances in antiplatelet therapyDeepak L Bhatt, Eric J TopolCleveland Clinic Journal of Medicine|July 29, 2003
Using C-reactive protein to assess cardiovascular disease riskMehdi H Shishehbor, Deepak L Bhatt, Eric J TopolEuropean Heart Journal|December 21, 2005
Aspirin and clopidogrel resistance: an emerging clinical entityThomas H Wang, Deepak L Bhatt, Eric J TopolStroke|January 24, 2004
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic eventsPeter A Ringleb, Deepak L Bhatt, Alan T Hirsch, et al.European Heart Journal|January 13, 2009
Patients with peripheral arterial disease in the CHARISMA trialPatrice P Cacoub, Deepak L Bhatt, P Gabriel Steg, et al.American Heart Journal|October 18, 2003
Preprocedural white blood cell count and death after percutaneous coronary interventionHitinder S Gurm, Deepak L Bhatt, Ritesh Gupta, et al.The Journal of Invasive Cardiology|February 5, 2004
The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patientsDavid S Lee, Deepak L Bhatt, David J Moliterno, et al.The American Journal of Cardiology|December 17, 2003
Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantationSorin J Brener, Deepak L Bhatt, David J Moliterno, et al.Pageof 209